Comparing Glycopyrrolate vs Umeclidinium
| Glycopyrrolate | Umeclidinium |
|
|---|
| Glycopyrrolate | Umeclidinium |
|
|||||||
|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Excessive Salivation, Anesthesia, COPD - Maintenance, Peptic Ulcer. Glycopyrrolate may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for COPD - Maintenance, COPD. Umeclidinium may also be used for purposes not listed in this medication guide. |
Related suggestions COPD, Maintenance
|
|||||||
| More about Glycopyrrolate | More about Umeclidinium | ||||||||
| Ratings & Reviews | |||||||||
|
Glycopyrrolate has an average rating of 8.3 out of 10 from a total of 23 ratings on Drugs.com. 74% of reviewers reported a positive effect, while 9% reported a negative effect. |
Umeclidinium has an average rating of 4.1 out of 10 from a total of 38 ratings on Drugs.com. 29% of reviewers reported a positive effect, while 61% reported a negative effect. |
||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||
|
View all Glycopyrrolate side effects |
View all Umeclidinium side effects |
||||||||
| Drug Class | |||||||||
| Generic Availability | |||||||||
|
Lower cost generic |
N/A |
||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||
View all Glycopyrrolate prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||
| Dosage Forms | |||||||||
|
N/A |
||||||||
| Brand Names | |||||||||
| Cuvposa, Dartisla ODT, Glycate, Glyrx-PF, Lonhala Magnair | Incruse Ellipta | ||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||
|
N/A |
11 hours |
||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
| Pregnancy Category | |||||||||
|
Category B
No proven risk in humans
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||
| Drug Interactions | |||||||||
|
A total of 203 drugs are known to interact with Glycopyrrolate:
|
A total of 103 drugs are known to interact with Umeclidinium:
|
||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||
| Disease Interactions | |||||||||
| First Approval Date | |||||||||
|
August 11, 1961 |
April 30, 2014 |
||||||||
| WADA Class View classifications | |||||||||
|
N/A |
N/A |
||||||||
| More Information | |||||||||
| Patient Resources | |||||||||
| Professional Resources | |||||||||
| Related Treatment Guide | |||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.